121 related articles for article (PubMed ID: 3018974)
41. Isolation and characterization of a human locus homologous to the transforming gene (v-fes) of feline sarcoma virus.
Trus MD; Sodroski JG; Haseltine WA
J Biol Chem; 1982 Mar; 257(6):2730-3. PubMed ID: 6277911
[TBL] [Abstract][Full Text] [Related]
42. Isolation of a feline leukaemia provirus containing the oncogene myc from a feline lymphosarcoma.
Levy LS; Gardner MB; Casey JW
Nature; 1984 Apr 26-May 2; 308(5962):853-6. PubMed ID: 6325921
[TBL] [Abstract][Full Text] [Related]
43. Infrequent ras oncogene point mutations in renal cell carcinoma.
Nanus DM; Mentle IR; Motzer RJ; Bander NH; Albino AP
J Urol; 1990 Jan; 143(1):175-8. PubMed ID: 2403598
[TBL] [Abstract][Full Text] [Related]
44. Expression of the myc cellular proto-oncogene in human thyroid tissue.
Yamashita S; Ong J; Fagin JA; Melmed S
J Clin Endocrinol Metab; 1986 Nov; 63(5):1170-3. PubMed ID: 3760117
[TBL] [Abstract][Full Text] [Related]
45. Expression of truncated transcripts of the proto-oncogene c-fps/fes in human lymphoma and lymphoid leukemia cell lines.
Jücker M; Roebroek AJ; Mautner J; Koch K; Eick D; Diehl V; Van de Ven WJ; Tesch H
Oncogene; 1992 May; 7(5):943-52. PubMed ID: 1373879
[TBL] [Abstract][Full Text] [Related]
46. A lack of direct role of hepatitis B virus in the activation of ras and c-myc oncogenes in human hepatocellular carcinogenesis.
Lee HS; Rajagopalan MS; Vyas GN
Hepatology; 1988; 8(5):1116-20. PubMed ID: 2843452
[TBL] [Abstract][Full Text] [Related]
47. Characterization of the feline c-abl proto-oncogene.
Schalken JA; van den Ouweland AM; Bloemers HP; van de Ven WJ
Biochim Biophys Acta; 1985 Feb; 824(2):104-12. PubMed ID: 2982404
[TBL] [Abstract][Full Text] [Related]
48. Molecular cloning and characterization of feline cellular genetic sequences homologous to the oncogene of the McDonough strain of feline sarcoma virus.
Verbeek JS; de Ruyter P; Bloemers HP; Van de Ven WJ
Virology; 1985 Mar; 141(2):322-7. PubMed ID: 3002022
[TBL] [Abstract][Full Text] [Related]
49. [Amplification of the expression of the c-myc oncogene in bronchial epidermoid carcinoma in man].
Douc-Rasy S; Terrier P; Kemeny JL; Amouroux J; Riou G
C R Acad Sci III; 1985; 301(13):621-6. PubMed ID: 3937573
[TBL] [Abstract][Full Text] [Related]
50. Analysis of the cellular proto-oncogene mht/raf: relationship to the 5' sequences of v-mht in avian carcinoma virus MH2 and v-raf in murine sarcoma virus 3611.
Flordellis CS; Kan NC; Lautenberger JA; Samuel KP; Garon CF; Papas TS
Virology; 1985 Mar; 141(2):267-74. PubMed ID: 3002017
[TBL] [Abstract][Full Text] [Related]
51. Elevated expression of the c-fes proto-oncogene in adult human myeloid leukemia cells in the absence of gene amplification.
Smithgall TE; Johnston JB; Bustin M; Glazer RI
J Natl Cancer Inst; 1991 Jan; 83(1):42-6. PubMed ID: 1984516
[TBL] [Abstract][Full Text] [Related]
52. Ha-ras oncogenes are activated by somatic alterations in human urinary tract tumours.
Fujita J; Yoshida O; Yuasa Y; Rhim JS; Hatanaka M; Aaronson SA
Nature; 1984 May 31-Jun 6; 309(5967):464-6. PubMed ID: 6328318
[TBL] [Abstract][Full Text] [Related]
53. Amplification and overexpression of the epidermal growth factor receptor gene in human renal-cell carcinoma.
Ishikawa J; Maeda S; Umezu K; Sugiyama T; Kamidono S
Int J Cancer; 1990 Jun; 45(6):1018-21. PubMed ID: 2351482
[TBL] [Abstract][Full Text] [Related]
54. An 8-kilobase abl RNA transcript in chronic myelogenous leukemia.
Gale RP; Canaani E
Proc Natl Acad Sci U S A; 1984 Sep; 81(18):5648-52. PubMed ID: 6091099
[TBL] [Abstract][Full Text] [Related]
55. Structural alteration of viral homologue of receptor proto-oncogene fms at carboxyl terminus.
Coussens L; Van Beveren C; Smith D; Chen E; Mitchell RL; Isacke CM; Verma IM; Ullrich A
Nature; 1986 Mar 20-26; 320(6059):277-80. PubMed ID: 2421165
[TBL] [Abstract][Full Text] [Related]
56. Studies on four cellular proto-oncogenes and their expression in PCC4 embryonal carcinoma cells: amplification of c-Ki-ras oncogene.
Vilette D; Emanoil-Ravier R; Tobaly J; Peries J
Biochem Biophys Res Commun; 1985 Apr; 128(2):513-9. PubMed ID: 2986619
[TBL] [Abstract][Full Text] [Related]
57. Comparison of cellular protooncogene activation and transformation-related activity of human melanocytes and metastatic melanoma.
Husain Z; FitzGerald GB; Wick MM
J Invest Dermatol; 1990 Nov; 95(5):571-5. PubMed ID: 2121834
[TBL] [Abstract][Full Text] [Related]
58. Oncogene expression in human tumors.
Tatosyan AG; Galetzki SA; Kisseljova NP; Asanova AA; Zborovskaya IB; Spitkovsky DD; Revasova ES; Martin P; Kisseljov FL
Int J Cancer; 1985 Jun; 35(6):731-6. PubMed ID: 4008101
[TBL] [Abstract][Full Text] [Related]
59. Determination of cellular oncogene rearrangement or amplification in ovarian adenocarcinomas.
Smith DM; Groff DE; Pokul RK; Bear JL; Delgado G
Am J Obstet Gynecol; 1989 Oct; 161(4):911-5. PubMed ID: 2801838
[TBL] [Abstract][Full Text] [Related]
60. Amplification of the c-myb oncogene in a case of human acute myelogenous leukemia.
Pelicci PG; Lanfrancone L; Brathwaite MD; Wolman SR; Dalla-Favera R
Science; 1984 Jun; 224(4653):1117-21. PubMed ID: 6585957
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]